New type of super killer immune cells found in cancer survivors
These multipronged T-cells could be levereged in novel therapies that make our immune system more effective at killing cancer.
Source: zmescience.com
Page 2 - Killert Cells News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Killert Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Killert Cells Today - Breaking & Trending Today
Tevogen Bio to Become Publicly Listed on NYSE via Business
Tevogen Bio Inc. (“Tevogen Bio”) is an advanced-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell...
Source: globenewswire.com
Stock Market | FinancialContent Business Page
FinancialContent fully hosted finance channel
Source: financialcontent.com
Anti-cancer CAR-T therapy reengineers T cells to kill tumors – and researchers are expanding the limited types of cancer it can target
Immunotherapy has the potential to eliminate tumors, but works best for select patients. Engineering T cells to bypass cancer’s defenses could help expand treatment eligibility to more patients.
Source: theconversation.com
![Rogue Killer T Cells in Leukemia Found as Culprit Behind Autoimmune Disease [Study] - Vimarsana News](https://1471793142.rsc.cdn77.org/data/thumbs/full/62870/650/0/0/0/leukemia.jpg)
Rogue Killer T Cells in Leukemia Found as Culprit Behind Autoimmune Disease [Study]
A new study describes rogue killer T cells as “rogue immune cells” to be one of the causes of autoimmune diseases.
Source: natureworldnews.com